Artelo Biosciences (ARTL) Share-based Compensation (2017 - 2025)
Artelo Biosciences (ARTL) recorded Share-based Compensation of $368,000 in Q4 2025, up 83.1% from $201,000 a year earlier but down 14.8% from the prior quarter.
Powered by 
Analysis
Artelo Biosciences (ARTL) Share-based Compensation (2017 - 2025) Analysis & Trends
For FY2025, Artelo Biosciences reported Share-based Compensation of $1.14 million, up 39.6% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of 24.6% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $818,000 in FY2024 (-19.8%), $1.02 million in FY2023 (-58.5%), $2.46 million in FY2022 and $1.53 million in FY2021 (+301.8%).
- Quarterly Share-based Compensation has ranged from $51,000 in Q1 2021 to $624,000 in Q1 2022 over the past five years.
- On a year-over-year basis, Share-based Compensation rose in two of the last eight quarters, with growth averaging 11.2%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 224.3% in Q2 2021, against a decline of 69.6% in Q1 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $432,000 (Q3 2025), $150,000 (Q2 2025) and $192,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Artelo Biosciences | 73,320.32 | -5.06 Mn | - | 368,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 368,000.00 |
| Sep 30, 2025 | 432,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Sep 30, 2024 | 209,000.00 |
| Jun 30, 2024 | 195,000.00 |
| Mar 31, 2024 | 213,000.00 |
| Dec 31, 2023 | 219,000.00 |
| Sep 30, 2023 | 222,000.00 |
| Jun 30, 2023 | 225,000.00 |
| Mar 31, 2023 | 354,000.00 |
| Dec 31, 2022 | 608,000.00 |
| Sep 30, 2022 | 607,000.00 |
| Jun 30, 2022 | 619,000.00 |
| Mar 31, 2022 | 624,000.00 |
| Nov 30, 2021 | 571,000.00 |
| Feb 28, 2021 | 341,817.00 |
| Nov 30, 2020 | 51,000.00 |
| Aug 31, 2020 | 54,602.00 |
API Access
Artelo Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();